9,778 Results

Phase III trial is initiated for pediatric patients for OV 101 in Angelman Syndrome. Ovid Therapeutics

 Added 11 hours ago

Ovid Therapeutics Inc. announced plans to move ahead with a single pivotal Phase III trial of OV 101 in pediatric...

FDA grants 510(k) approval for Vanguard IEP Peripheral Balloon Angioplasty System.- Contego Medical

 Added 11 hours ago

Contego Medical announced that the FDA has granted 510(k) clearance for its Vanguard IEP Peripheral Balloon Angioplasty System with Integrated...

Interim analysis of long-term study shows Zydis safe for migraine.- Biohaven Pharmaceutical.

 Added 1 day ago

Biohaven Pharmaceutical announced initial positive results from its ongoing long-term, open-label safety study of Zydis (rimegepant), for the acute treatment...

FDA approves prescription digital therapeutic, reSET-O for patients with opioid use disorder. Sandoz.

 Added 1 day ago

Sandoz Inc., a division of Novartis, and Pear Therapeutics, Inc., the leader in prescription digital therapeutics, announced that the FDA...

Phase III study of Liletta for contraception published in American Journal of Obstetrics & Gynecology.- Medicines360/Allergan.

 Added 1 day ago

Medicines360/Allergan announced newly published data finding that Liletta (levonorgestrel releasing intrauterine system) is highly efficacious in preventing pregnancy over five...

Real-world data supports usage of Oncotype DX Breast Recurrence Score test in breast cancer.- Genomic Health.

 Added 1 day ago

Long-term outcomes data from a large population-based study further support the utility of the Oncotype DX Breast Recurrence Score test,...

New data demonstrates IV meloxicam’s effect on platelet function.- Recro Pharma

 Added 1 day ago

Recro Pharma, Inc. announced a poster presentation highlighting intravenous (IV) meloxicam’s effect on platelet function at the 72nd PostGraduate Assembly...

Positive phase III results for F 627 in neutropenia in breast cancer.- Generon.

 Added 2 days ago

Generon BioMed announced positive results from a placebo-controlled trial with F 627 (benegrastim), a recombinant human Granulocyte Colony Stimulating Factor...

Data analysis of MONALEESA trials shows efficacy and tolerability of Kisqali in HR+/HER2- advanced breast cancer in patients with difficult-to-treat visceral disease.-Novartis

 Added 3 days ago

Novartis announced data from subgroup analyses of the three pivotal Phase III MONALEESA trials showing that Kisqali (ribociclib) plus endocrine...

Positive Phase III trial for Zydis orally dissolving tablet to treat acute migraine.- Biohaven,

 Added 3 days ago

Biohaven Pharmaceutical Holding Company Ltd.announced positive topline results from a randomized, controlled Phase III clinical trial (BHV 3000-303 or Study...

Load more